Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

STRATA Skin Sciences (SSKN) Long-Term Debt Issuances (2019 - 2021)

STRATA Skin Sciences' Long-Term Debt Issuances history spans 6 years, with the latest figure at $8.0 million for Q3 2021.

On a quarterly basis, Long-Term Debt Issuances rose 416.46% to $8.0 million in Q3 2021 year-over-year; TTM through Dec 2022 was $8.0 million, a 0.0% change, with the full-year FY2023 number at $7.0 million, changed N/A from a year prior.
Long-Term Debt Issuances hit $8.0 million in Q3 2021 for STRATA Skin Sciences, up from $2.5 million in the prior quarter.
Over the last five years, Long-Term Debt Issuances for SSKN hit a ceiling of $8.0 million in Q3 2021 and a floor of -$2.5 million in Q3 2020.
Historically, Long-Term Debt Issuances has averaged $3.8 million across 3 years, with a median of $4.9 million in 2019.
Biggest five-year swings in Long-Term Debt Issuances: plummeted 65.25% in 2020 and later surged 416.46% in 2021.
Tracing SSKN's Long-Term Debt Issuances over 3 years: stood at $7.3 million in 2019, then plummeted by 65.25% to $2.5 million in 2020, then soared by 216.46% to $8.0 million in 2021.
Business Quant data shows Long-Term Debt Issuances for SSKN at $8.0 million in Q3 2021, $2.5 million in Q4 2020, and -$2.5 million in Q3 2020.